CDMO

View All

Pharma News and Analysis for BMS, Sandoz, and Pfizer
BMS Sells NY Biologics Plant; FDA Approves Mitsubishi Tanabe’s Radicava, Love Pharma Acquires MicroDoz; Sandoz Launches Generic of Roche’s Esbriet; Pfizer to Acquire Biohaven Pharma; eureKARE’s Cell and Gene Therapy CDMO; Atamyo’s LGMD Gene Therapies; FDA approves Eli Lilly’s Type 2 Diabetes Treatment

Love Pharma Completes the Acquisition of MicroDoz Therapy LOVE Pharma Co. has announced the completion of its acquisition of MicroDoz Theraphy Inc. ("MicroDoz"). Love Pharma holds exclusive manufacturing, marketing, packaging, selling, and distribution licenses in Europe, the United Kingdom, and North America. U...

Find More

contract-organizations-impacting-pharma-development-and-manufacturing
Contract Organizations Impacting Pharma Development and Manufacturing

Contract Development and Manufacturing Organisation (CDMO) is a term for organizations providing extensive services and solutions to the pharmaceutical and biotech industry starting from the drug development process to packaging of the product. These companies deliver a broad range of services, such as clinical res...

Find More

Cambrex acquires Avista; Sobi pays $50M; LEO Pharma signs deal; Boston Scientific remunerates

Cambrex takes over Avista in USD 250 Million agreement Cambrex, life sciences company, is taking over Avista Pharma Solutions with a deal of USD 250 million to become a leading contract development and manufacturing organization (CDMO). The agreement includes the early-stage drug development and manufacturing capabi...

Find More

transthyretin amyloidosis
Symdeko’s approval; Erytech target solid tumors; Oncologie snapped bavituximab; Merck delivers

Vertex pharmaceutical’s growth story in biotech with Symdeko’s approval FDA has recently approved Vertex Pharmaceutical’s latest combination treatment, Symdeko, to serve the cystic fibrosis patient population. Symdeko's annual list price has been set at USD 292,000. Symdeko has paired with a fresh corrector, tezacaf...

Find More

Piramal buys; Abbott Buys Glomed; Merck Divesting; Takeda set to sell; Teva gets clearance

Piramal buys another U.S. manufacturer operation India’s Piramal has decided to have a manufacturing operations based in the U.S., and has now bought another operation after it bought a sterile manufacturing operation last year. The company bought Midwestern-based CDMO for $42.95 million in cash, with an additional ...

Find More